Log In
Print
BCIQ
Print
Print this Print this
 

APN201

  Manage Alerts
Collapse Summary General Information
Company Apeiron Biologics AG
DescriptionTopical liposomal formulation of a recombinant human superoxide dismutase (rhSOD)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase II
Standard Indication Dermatology (unspecified)
Indication DetailsPrevent radiation-induced dermatitis in breast cancer patients; Treat skin damage resulting from radiation treatment
Regulatory Designation

Partner

Polymun Scientific Immunbiologische Forschung GmbH


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today